X2VY06B
Restriction Thoracic Aortic Arch and Descending Thoracic Aorta to New Technology Group 11 with Intraluminal Device, Uncovered with Support Cuff, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | V Restriction |
| Body Part | Y Thoracic Aortic Arch and Descending Thoracic Aorta |
| Approach | 0 Open |
| Device | 6 Intraluminal Device, Uncovered with Support Cuff |
| Qualifier | B New Technology Group 11 |
Operation Definition
Partially closing an orifice or the lumen of a tubular body part
Procedure Overview
This family covers procedures that narrow rather than close off a blood vessel or chamber, most notably placement of a coronary sinus reducer for patients with disabling angina that has not responded to medication, bypass surgery, or stenting, and whose coronary arteries are not amenable to further revascularization. The device is an hourglass-shaped implant delivered by catheter into the coronary sinus, the vein that drains blood from the heart muscle back to the right atrium. By creating a controlled narrowing at that point, it raises pressure in the small veins upstream, which appears to redistribute blood flow toward oxygen-starved areas of heart muscle and reduce chest pain episodes.
Patients considered for this therapy typically have exhausted standard options and continue to have frequent angina that limits daily activity. The procedure is done in a catheterization lab under fluoroscopic guidance, generally as an outpatient or short-stay procedure, and does not involve opening the chest.
Anatomy & Axis Detail
Thoracic Aortic Arch and Descending Thoracic Aorta
This combined body part covers the thoracic aortic arch, which gives rise to the brachiocephalic, left common carotid, and left subclavian arteries, together with the descending thoracic aorta extending to the diaphragm. Restriction across this extended region with new-technology devices is generally reserved for complex arch pathology, such as a dissection or aneurysm that begins at or involves the arch and extends distally, requiring a device that narrows the lumen continuously through both zones. Because the arch vessels branch directly from this segment, the procedure demands careful device design or adjunctive branch management to maintain flow to the head and upper extremities while achieving restriction of the diseased aorta. Coders should verify from the report that the treated length genuinely spans the arch into the descending thoracic aorta before assigning this value rather than a single-region code.
Approach: Open
Open approach in New Technology denotes access to the target site through a surgical incision that exposes the body part directly to view and instrumentation. It stands apart from percutaneous and endoscopic approaches, which achieve access through small punctures or existing openings rather than a deliberate surgical opening of tissue.
Device / Substance / Technology: Intraluminal Device, Uncovered with Support Cuff
This value describes an intraluminal device that is uncovered along its main body but incorporates a support cuff, a reinforced segment intended to improve fixation or sealing at one end. It is distinguished from fully covered intraluminal devices by allowing tissue or side-branch access through the uncovered portions, while the cuff still provides localized structural support. The design balances flow preservation with secure anchoring.
Qualifier: New Technology Group 11
This qualifier designates Group 11, the most recent cohort at the time of its introduction, grouping technologies newly approved for New Technology section reporting in that fiscal year. Like every group value in this axis, it functions as an administrative marker rather than a description of the clinical intervention, which is captured elsewhere in the code. Its main point of confusion is with Group 10, the immediately preceding annual release.
Coding & Documentation
Assignment depends on documentation identifying the coronary sinus as the treated body part and confirming that a new-technology intraluminal device was deployed, since this root operation and device combination is what distinguishes the procedure from a standard coronary intervention. The operative note should specify catheter-based delivery and device sizing/deployment, along with confirmation of correct final position by contrast venography. A common assignment error is defaulting to a generic Dilation or Occlusion code for coronary sinus work, when the reducer's mechanism is a partial, fixed narrowing rather than either widening a vessel or completely blocking it. Coders should also verify the approach value reflects percutaneous access and confirm the device is captured under the correct new-technology group rather than a conventional device value.